Addressing Missing Data in Clinical Trials With a Hybrid Control Arm
ABSTRACT Randomized trials have long been the standard for evaluating experimental treatments in medical and pharmacological studies, but the associated time and cost have spurred research into designs that augment randomized studies with data from external sources. Hybrid control arms offer the promise of improved pre...